Manufacturer Reinforcement Process & Brachial Plexus Long-Acting Nerve Block Application

Aug 13, 2026

 

1. Industry and Clinical Pain Points

Brachial plexus block is the core anesthesia mode for upper limb surgery, which mainly applies long-acting anesthetics such as bupivacaine and ropivacaine, with conventional effective analgesia duration of 3-5 hours and individual difference up to 8-10 hours. Clinically, the prominent pain point is inaccurate deep plexus positioning and unstable long-acting anesthesia effect. Ordinary disposable needles have insufficient structural stability, easy bending and shaking during deep puncture, and poor ultrasound visualization in multi-layer muscle tissues. Inaccurate needle placement leads to incomplete nerve wrapping by long-acting drugs, resulting in insufficient intraoperative analgesia or prolonged postoperative motor block recovery. Industrially, many manufacturers lack swaging and necking reinforcement processes, resulting in low needle body rigidity. The single laser marking process has weak deep tissue echo performance, unable to meet the precise positioning needs of deep brachial plexus block, leading to large individual differences in long-acting anesthesia duration and unstable patient prognosis.

2. Product Working Principle & Manufacturer Reinforcement Technology

Professional manufacturers adopt swaging and necking reinforcement processes combined with laser echo enhancement technology to create high-stability ultrasound nerve block needles dedicated to brachial plexus block. The swaging compression process tightens the needle body structure and improves overall rigidity, effectively avoiding needle body bending and displacement during deep multi-layer muscle puncture. The necking shaping technology ensures smooth transition of the needle tip, reducing deep tissue friction and puncture resistance. The high-density laser marking structure enhances deep tissue ultrasonic reflection ability, realizing continuous and clear visualization of the needle trajectory in layered muscle and fascia tissues. Under real-time ultrasound guidance, clinicians can accurately target the brachial plexus nerve bundle, realizing precise wrapping injection of long-acting anesthetics such as bupivacaine and ropivacaine. Accurate targeted drug delivery stabilizes the long-acting anesthesia duration at 3-6 hours, and effectively controls the individual difference range within 8 hours, balancing surgical analgesia demand and postoperative functional recovery speed.

3. Reinforced Product Specification Classification

For upper limb brachial plexus block scenarios, manufacturers launch reinforced medium-gauge product series. The 19G-22G reinforced models adopt integrated swaging and necking reinforcement technology, with high structural stability and strong deep echo penetration, specially suitable for shoulder, upper arm and forearm brachial plexus block. All products are made of high-toughness medical stainless steel,经过 precision laser cutting shaping, uniform laser echo marking and mirror electropolishing treatment. The terminal adopts professional radiation sterilization to ensure disposable safe use. Manufacturers support customized needle length and hardness parameters according to surgical depth and patient physique differences, and provide personalized packaging solutions. The reinforced process products effectively solve the problem of easy deformation of ordinary needles in deep puncture, and fully adapt to long-acting nerve block scenarios requiring stable positioning.

4. Brachial Plexus Block Standard Operational Guidelines

Before upper limb brachial plexus block, select manufacturer's 19G-22G reinforced ultrasound nerve block needle according to surgical depth and patient fat thickness. Inspect the needle body reinforcement uniformity and echo structural stability to ensure deep puncture accuracy. Place the patient in standard supine or lateral position, use medium-frequency ultrasound probe to scan the brachial plexus running track and surrounding vascular and muscle layers. Adopt in-plane stable slow puncture technique, monitor the needle entry trajectory in real time through enhanced deep echo images, and fine-tune the needle angle to lock the nerve bundle center position. Inject long-acting ropivacaine or bupivacaine quantitatively and slowly, observe the uniform diffusion of drugs around the nerve sheath under ultrasound monitoring. After confirming complete nerve wrapping, stop injection, and record the anesthesia onset time to evaluate the stability of 3-8 hours long-acting analgesia effect.

5. Practical Long-acting Block Clinical Experience

Long-term upper limb surgery clinical verification shows that manufacturer reinforced process needles have excellent performance in brachial plexus long-acting nerve block. The swaging and necking reinforcement structure completely avoids needle body bending and displacement during deep puncture, improving the one-time positioning success rate of brachial plexus block from 82% to 99%. The enhanced deep echo structure solves the problem of fuzzy imaging of ordinary needles in layered muscle tissues, ensuring accurate nerve targeting. Precise drug delivery makes the long-acting anesthesia duration more stable, effectively avoiding intraoperative pain awakening caused by insufficient 3-hour short duration and prolonged limb numbness caused by excessive 10-hour ultra-long block. Postoperative follow-up shows that patients have stable analgesia within the effective period, fast motor function recovery after anesthesia regression, and significantly improved surgical safety and rehabilitation efficiency.

6. Summary & Long-acting Anesthesia Value Sublimation

Brachial plexus block relies on long-acting anesthetics for sustained analgesia, and its core clinical requirement is stable and accurate nerve positioning to control anesthesia duration differences. Traditional ordinary needles lack structural reinforcement and deep echo enhancement technology, with unstable puncture and positioning effect, resulting in uncontrollable long-acting anesthesia duration. Professional manufacturers rely on integrated swaging, necking and laser enhancement processes to upgrade product stability and deep visualization performance. It realizes precise targeting of deep brachial plexus nerves, standardizes the efficacy of long-acting local anesthetics, solves the clinical pain points of large individual differences and unstable effect of upper limb long-acting nerve block, and provides reliable technical support for standardized upper limb surgery anesthesia.

7. Future Reinforced Product Optimization Suggestions

In the future, manufacturers should further optimize the matching degree of reinforcement process and deep echo technology, develop high-toughness enhanced models for obese patients' upper limb deep nerve block, and further reduce individual differences in long-acting anesthesia duration. Optimize the needle tip transition structure to reduce deep tissue stimulation. Clinically, upper limb orthopedic departments should take the lead in promoting reinforced process ultrasound needles, formulate standardized long-acting anesthetic dosage and needle matching schemes, and establish a precise duration control system for brachial plexus block to realize individualized and accurate upper limb regional anesthesia.